"Supreme Court Case on Mifepristone: Impact on Abortion Access"

The U.S. Supreme Court is hearing a case that could impact access to mifepristone, a key abortion drug, with the central dispute focusing on the FDA's safety oversight. Medical professionals tout mifepristone as safe, while opponents attribute "emergency complications" to the drug. Studies show that serious adverse events from mifepristone are rare, with the pill resulting in a completed abortion 97.4% of the time. The FDA's decision to ease restrictions on mifepristone, allowing mail-order distribution, is at the heart of the case.